Skip to main content
Erschienen in: Supportive Care in Cancer 7/2019

06.04.2019 | Review Article

Effect of sarcopenia on clinical outcomes following digestive carcinoma surgery: a meta-analysis

verfasst von: Hongxia Hua, Xinyi Xu, Yu Tang, Ziqi Ren, Qin Xu, Li Chen

Erschienen in: Supportive Care in Cancer | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

The effect of sarcopenia on digestive carcinoma surgery outcomes is controversial. We aimed to assess the effect of sarcopenia defined by the European Working Group on Sarcopenia in Older People (EWGSOP) or the Asian Working Group for Sarcopenia (AWGS) on outcomes following digestive carcinoma surgery.

Methods

Eligible studies were searched from PubMed, EMBASE and other databases from inception to April 2018. We conducted a meta-analysis to estimate the risk ratios or mean differences of outcomes in the sarcopenia group versus the non-sarcopenia group. Stratified analyses and sensitivity analyses were performed.

Results

We included 11 cohort studies, with a sarcopenia prevalence ranging from 11.6 to 33.0%. Sarcopenia was associated with an increased risk of total complications (RR = 1.87, P < 0.00001), major complications (RR = 2.45, P = 0.002), re-admissions (RR = 2.53,P < 0.0001), infections (RR = 2.23, P = 0.09), severe infections (RR = 2.96, P = 0.04), 30-day mortality (RR = 3.36, P = 0.001), longer hospital stay (MD = 4.61, P = 0.001) and increased hospitalization expenditures (SMD = 0.25, P = 0.02). Sarcopenia differentially affected outcomes when stratified, and the results were stable.

Conclusions

Sarcopenia defined by the EWGSOP or AWGS Consensus was a high-risk factor for digestive carcinoma surgery outcomes. Different tumour site and muscle mass measurements are the sources of heterogeneity. More high-quality studies are needed.
Literatur
2.
Zurück zum Zitat Thrumurthy SG, Chaudry MA, Hochhauser D, Mughal M (2013) The diagnosis and management of gastric cancer. BMJ (Clinical research ed) 347(nov04 1):f6367 Thrumurthy SG, Chaudry MA, Hochhauser D, Mughal M (2013) The diagnosis and management of gastric cancer. BMJ (Clinical research ed) 347(nov04 1):f6367
3.
Zurück zum Zitat Papenfuss WA, Kukar M, Oxenberg J, Attwood K, Nurkin S, Malhotra U, Wilkinson NW (2014) Morbidity and mortality associated with gastrectomy for gastric cancer. Ann Surg Oncol 21(9):3008–3014CrossRefPubMed Papenfuss WA, Kukar M, Oxenberg J, Attwood K, Nurkin S, Malhotra U, Wilkinson NW (2014) Morbidity and mortality associated with gastrectomy for gastric cancer. Ann Surg Oncol 21(9):3008–3014CrossRefPubMed
4.
Zurück zum Zitat Nations DEU (2013) World population prospects: the 2012 revision highlights and advance tables. New York United Nations Department of Economic & Social Affairs Nations DEU (2013) World population prospects: the 2012 revision highlights and advance tables. New York United Nations Department of Economic & Social Affairs
5.
Zurück zum Zitat Wagner D, Demarco MA, Amini N, Buttner S, Segev D, Gani F, Pawlik TM (2016) Role of frailty and sarcopenia in predicting outcomes among patients undergoing gastrointestinal surgery. World J Gastrointest Surg 8(1):27–40CrossRefPubMedPubMedCentral Wagner D, Demarco MA, Amini N, Buttner S, Segev D, Gani F, Pawlik TM (2016) Role of frailty and sarcopenia in predicting outcomes among patients undergoing gastrointestinal surgery. World J Gastrointest Surg 8(1):27–40CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Takeshita H, Ichikawa D, Kubota T, Okamoto K, Shiozaki A, Fujiwara H, Otsuji E (2013) Surgical outcomes of gastrectomy for elderly patients with gastric cancer. World J Surg 37(12):2891–2898CrossRefPubMed Takeshita H, Ichikawa D, Kubota T, Okamoto K, Shiozaki A, Fujiwara H, Otsuji E (2013) Surgical outcomes of gastrectomy for elderly patients with gastric cancer. World J Surg 37(12):2891–2898CrossRefPubMed
8.
Zurück zum Zitat Binay Safer V, Safer U, Kaplan M, Terekeci H, Top C (2015) Limitations of the definition of sarcopenia in cancer surgery. J Surg Oncol 112(1):116–116CrossRefPubMed Binay Safer V, Safer U, Kaplan M, Terekeci H, Top C (2015) Limitations of the definition of sarcopenia in cancer surgery. J Surg Oncol 112(1):116–116CrossRefPubMed
9.
Zurück zum Zitat Cruz-Jentoft AJ, Jean Pierre B, Bauer JM, Yves B, Tommy C, Francesco L, Martin FC, Jean-Pierre M, Yves R, Schneider SM (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423CrossRefPubMedPubMedCentral Cruz-Jentoft AJ, Jean Pierre B, Bauer JM, Yves B, Tommy C, Francesco L, Martin FC, Jean-Pierre M, Yves R, Schneider SM (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O, Lee JS, Lee WJ, Lee Y, Liang CK, Limpawattana P, Lin CS, Peng LN, Satake S, Suzuki T, Won CW, Wu CH, Wu SN, Zhang T, Zeng P, Akishita M, Arai H (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15(2):95–101CrossRefPubMed Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O, Lee JS, Lee WJ, Lee Y, Liang CK, Limpawattana P, Lin CS, Peng LN, Satake S, Suzuki T, Won CW, Wu CH, Wu SN, Zhang T, Zeng P, Akishita M, Arai H (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15(2):95–101CrossRefPubMed
11.
Zurück zum Zitat Makiura D, Ono R, Inoue J, Kashiwa M, Oshikiri T, Nakamura T, Kakeji Y, Sakai Y, Miura Y (2016) Preoperative sarcopenia is a predictor of postoperative pulmonary complications in esophageal cancer following esophagectomy: a retrospective cohort study. Journal of Geriatric Oncology 7(6):430–436CrossRefPubMed Makiura D, Ono R, Inoue J, Kashiwa M, Oshikiri T, Nakamura T, Kakeji Y, Sakai Y, Miura Y (2016) Preoperative sarcopenia is a predictor of postoperative pulmonary complications in esophageal cancer following esophagectomy: a retrospective cohort study. Journal of Geriatric Oncology 7(6):430–436CrossRefPubMed
12.
Zurück zum Zitat Wang SL, Zhuang CL, Huang DD, Pang WY, Lou N, Chen FF, Zhou CJ, Shen X, Yu Z (2016) Sarcopenia adversely impacts postoperative clinical outcomes following gastrectomy in patients with gastric cancer: a prospective study. Ann Surg Oncol 23(2):556–564CrossRefPubMed Wang SL, Zhuang CL, Huang DD, Pang WY, Lou N, Chen FF, Zhou CJ, Shen X, Yu Z (2016) Sarcopenia adversely impacts postoperative clinical outcomes following gastrectomy in patients with gastric cancer: a prospective study. Ann Surg Oncol 23(2):556–564CrossRefPubMed
15.
Zurück zum Zitat Haehling SV, Morley JE, Anker SD (2010) An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle 1(2):129–133CrossRef Haehling SV, Morley JE, Anker SD (2010) An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle 1(2):129–133CrossRef
16.
Zurück zum Zitat Morley JE, Anker SD, Haehling SV (2014) Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology—update 2014. J Cachexia Sarcopenia Muscle 5(4):253–259CrossRefPubMedPubMedCentral Morley JE, Anker SD, Haehling SV (2014) Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology—update 2014. J Cachexia Sarcopenia Muscle 5(4):253–259CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Muscaritoli M, Anker SJ, Aversa Z, Bauer JM, Biolo G, Boirie Y, Bosaeus I, Cederholm T, Costelli P, Fearon KC (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29(2):154–159CrossRefPubMed Muscaritoli M, Anker SJ, Aversa Z, Bauer JM, Biolo G, Boirie Y, Bosaeus I, Cederholm T, Costelli P, Fearon KC (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29(2):154–159CrossRefPubMed
18.
Zurück zum Zitat Laviano A, Meguid MM, Inui A, Muscaritoli M, Rossi-Fanelli F (2005) Therapy insight: cancer anorexia-cachexia syndrome—when all you can eat is yourself. Nat Clin Pract Oncol 2(3):158–165CrossRefPubMed Laviano A, Meguid MM, Inui A, Muscaritoli M, Rossi-Fanelli F (2005) Therapy insight: cancer anorexia-cachexia syndrome—when all you can eat is yourself. Nat Clin Pract Oncol 2(3):158–165CrossRefPubMed
19.
Zurück zum Zitat Scott D, Blizzard L, Fell J, Giles G, Jones G (2010) Associations between dietary nutrient intake and muscle mass and strength in community-dwelling older adults: the Tasmanian Older Adult Cohort Study. J Am Geriatr Soc 58(11):2129–2134CrossRefPubMed Scott D, Blizzard L, Fell J, Giles G, Jones G (2010) Associations between dietary nutrient intake and muscle mass and strength in community-dwelling older adults: the Tasmanian Older Adult Cohort Study. J Am Geriatr Soc 58(11):2129–2134CrossRefPubMed
20.
Zurück zum Zitat Valenzuela RER, Ponce JA, Morales-Figueroa GG, Muro KA, Carreón VR, Alemán-Mateo H (2013) Insufficient amounts and inadequate distribution of dietary protein intake in apparently healthy older adults in a developing country: implications for dietary strategies to prevent sarcopenia. Clin Interv Aging 8(2):1143–1148PubMedPubMedCentral Valenzuela RER, Ponce JA, Morales-Figueroa GG, Muro KA, Carreón VR, Alemán-Mateo H (2013) Insufficient amounts and inadequate distribution of dietary protein intake in apparently healthy older adults in a developing country: implications for dietary strategies to prevent sarcopenia. Clin Interv Aging 8(2):1143–1148PubMedPubMedCentral
21.
Zurück zum Zitat Zhang G, Meng S, Li R, Ye J, Zhao L (2017) Clinical significance of sarcopenia in the treatment of patients with primary hepatic malignancies, a systematic review and meta-analysis. Oncotarget 8(60):102474–102485PubMedPubMedCentral Zhang G, Meng S, Li R, Ye J, Zhao L (2017) Clinical significance of sarcopenia in the treatment of patients with primary hepatic malignancies, a systematic review and meta-analysis. Oncotarget 8(60):102474–102485PubMedPubMedCentral
22.
Zurück zum Zitat Voron T, Tselikas L, Pietrasz D, Pigneur F, Laurent A, Compagnon P, Salloum C, Luciani A, Azoulay D (2015) Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg 261(6):1173–1183CrossRefPubMed Voron T, Tselikas L, Pietrasz D, Pigneur F, Laurent A, Compagnon P, Salloum C, Luciani A, Azoulay D (2015) Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg 261(6):1173–1183CrossRefPubMed
23.
Zurück zum Zitat Peng P, Hyder O, Firoozmand A, Kneuertz P, Schulick RD, Huang D, Makary M, Hirose K, Edil B, Choti MA (2012) Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg 16(8):1478–1486CrossRefPubMedPubMedCentral Peng P, Hyder O, Firoozmand A, Kneuertz P, Schulick RD, Huang D, Makary M, Hirose K, Edil B, Choti MA (2012) Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg 16(8):1478–1486CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE (2012) Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 107(6):931–936CrossRefPubMedPubMedCentral Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE (2012) Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 107(6):931–936CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Nakashima Y, Saeki H, Nakanishi R, Sugiyama M, Kurashige J, Oki E, Maehara Y (2017) Assessment of sarcopenia as a predictor of poor outcomes after esophagectomy in elderly patients with esophageal cancer. Ann Surg 267:1 Nakashima Y, Saeki H, Nakanishi R, Sugiyama M, Kurashige J, Oki E, Maehara Y (2017) Assessment of sarcopenia as a predictor of poor outcomes after esophagectomy in elderly patients with esophageal cancer. Ann Surg 267:1
26.
Zurück zum Zitat Huang DD, Wang SL, Zhuang CL, Zheng BS, Lu JX, Chen FF, Zhou CJ, Shen X, Yu Z (2015) Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer. Colorectal Dis Off J Assoc Coloproctol Great Britain Ireland 17(11):O256–O264CrossRef Huang DD, Wang SL, Zhuang CL, Zheng BS, Lu JX, Chen FF, Zhou CJ, Shen X, Yu Z (2015) Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer. Colorectal Dis Off J Assoc Coloproctol Great Britain Ireland 17(11):O256–O264CrossRef
27.
Zurück zum Zitat Jones K, Gordon-Weeks A, Coleman C, Silva M (2017) Radiologically determined sarcopenia predicts morbidity and mortality following abdominal surgery: a systematic review and meta-analysis. World J Surg 41(9):2266–2279CrossRefPubMedPubMedCentral Jones K, Gordon-Weeks A, Coleman C, Silva M (2017) Radiologically determined sarcopenia predicts morbidity and mortality following abdominal surgery: a systematic review and meta-analysis. World J Surg 41(9):2266–2279CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Simonsen C, De HP, Bjerre ED, Suetta C, Hojman P, Pedersen BK, Svendsen LB, Christensen JF (2018) Sarcopenia and postoperative complication risk in gastrointestinal surgical oncology: a meta-analysis. Ann Surg 268(1):1CrossRef Simonsen C, De HP, Bjerre ED, Suetta C, Hojman P, Pedersen BK, Svendsen LB, Christensen JF (2018) Sarcopenia and postoperative complication risk in gastrointestinal surgical oncology: a meta-analysis. Ann Surg 268(1):1CrossRef
29.
Zurück zum Zitat Fukuda Y, Yamamoto K, Hirao M, Nishikawa K, Nagatsuma Y, Nakayama T, Tanikawa S, Maeda S, Uemura M, Miyake M (2015) Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy. Gastric Cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 34(3):S227–S227 Fukuda Y, Yamamoto K, Hirao M, Nishikawa K, Nagatsuma Y, Nakayama T, Tanikawa S, Maeda S, Uemura M, Miyake M (2015) Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy. Gastric Cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 34(3):S227–S227
30.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Clinical research ed) Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Clinical research ed)
31.
Zurück zum Zitat Dindo D, Demartines N, Clavien P (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien P (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Chuling F, Hui H, Zuojun X (2016) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies Chuling F, Hui H, Zuojun X (2016) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies
33.
Zurück zum Zitat Doi SAR, Barendregt JJ, Khan S, Thalib L, Williams GM (2015) Advances in the meta-analysis of heterogeneous clinical trials I: the inverse variance heterogeneity model. Contemporary Clin Trials 45(Pt A):130–138CrossRef Doi SAR, Barendregt JJ, Khan S, Thalib L, Williams GM (2015) Advances in the meta-analysis of heterogeneous clinical trials I: the inverse variance heterogeneity model. Contemporary Clin Trials 45(Pt A):130–138CrossRef
34.
Zurück zum Zitat Shuster JJ (2011) Review: Cochrane handbook for systematic reviews for interventions, Version 5.1.0, published 3/2011. Julian P.T. Higgins and Sally Green, Editors. Res Synth Methods 2 (2):126–130 Shuster JJ (2011) Review: Cochrane handbook for systematic reviews for interventions, Version 5.1.0, published 3/2011. Julian P.T. Higgins and Sally Green, Editors. Res Synth Methods 2 (2):126–130
35.
Zurück zum Zitat Harimoto N, Yoshizumi T, Izumi T, Motomura T, Harada N, Itoh S, Ikegami T, Uchiyama H, Soejima Y, Nishie A (2017) Clinical outcomes of living liver transplantation according to the presence of sarcopenia as defined by skeletal muscle mass, hand grip, and gait speed. Transplant Proc 49(9):2144–2152CrossRefPubMed Harimoto N, Yoshizumi T, Izumi T, Motomura T, Harada N, Itoh S, Ikegami T, Uchiyama H, Soejima Y, Nishie A (2017) Clinical outcomes of living liver transplantation according to the presence of sarcopenia as defined by skeletal muscle mass, hand grip, and gait speed. Transplant Proc 49(9):2144–2152CrossRefPubMed
36.
Zurück zum Zitat Huang DD, Chen XX, Chen XY, Wang SL, Shen X, Chen XL, Yu Z, Zhuang CL (2016) Sarcopenia predicts 1-year mortality in elderly patients undergoing curative gastrectomy for gastric cancer: a prospective study. J Cancer Res Clin Oncol 142(11):1–10CrossRef Huang DD, Chen XX, Chen XY, Wang SL, Shen X, Chen XL, Yu Z, Zhuang CL (2016) Sarcopenia predicts 1-year mortality in elderly patients undergoing curative gastrectomy for gastric cancer: a prospective study. J Cancer Res Clin Oncol 142(11):1–10CrossRef
37.
Zurück zum Zitat Kaido T, Ogawa K, Fujimoto Y, Ogura Y, Hata K, Ito T, Tomiyama K, Yagi S, Mori A, Uemoto S (2013) Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant 13(6):1549–1556CrossRefPubMed Kaido T, Ogawa K, Fujimoto Y, Ogura Y, Hata K, Ito T, Tomiyama K, Yagi S, Mori A, Uemoto S (2013) Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant 13(6):1549–1556CrossRefPubMed
38.
Zurück zum Zitat Kawamura T, Makuuchi R, Tokunaga M, Tanizawa Y, Bando E, Yasui H, Aoyama T, Inano T, Terashima M (2018) Long-term outcomes of gastric cancer patients with preoperative sarcopenia. Ann Surg Oncol 4:1–8 Kawamura T, Makuuchi R, Tokunaga M, Tanizawa Y, Bando E, Yasui H, Aoyama T, Inano T, Terashima M (2018) Long-term outcomes of gastric cancer patients with preoperative sarcopenia. Ann Surg Oncol 4:1–8
40.
Zurück zum Zitat Makiura D, Ono R, Inoue J, Fukuta A, Kashiwa M, Miura Y, Oshikiri T, Nakamura T, Kakeji Y, Sakai Y (2018) Impact of sarcopenia on unplanned readmission and survival after Esophagectomy in patients with esophageal cancer. Ann Surg Oncol 25(2):1–9CrossRef Makiura D, Ono R, Inoue J, Fukuta A, Kashiwa M, Miura Y, Oshikiri T, Nakamura T, Kakeji Y, Sakai Y (2018) Impact of sarcopenia on unplanned readmission and survival after Esophagectomy in patients with esophageal cancer. Ann Surg Oncol 25(2):1–9CrossRef
41.
Zurück zum Zitat Zhou CJ, Zhang FM, Zhang FY, Yu Z, Chen XL, Shen X, Zhuang CL, Chen XX (2017) Sarcopenia: a new predictor of postoperative complications for elderly gastric cancer patients who underwent radical gastrectomy. J Surg Res 211:137–146CrossRefPubMed Zhou CJ, Zhang FM, Zhang FY, Yu Z, Chen XL, Shen X, Zhuang CL, Chen XX (2017) Sarcopenia: a new predictor of postoperative complications for elderly gastric cancer patients who underwent radical gastrectomy. J Surg Res 211:137–146CrossRefPubMed
42.
Zurück zum Zitat Visser M, Deeg DP (2003) Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 88(12):5766–5772CrossRefPubMed Visser M, Deeg DP (2003) Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 88(12):5766–5772CrossRefPubMed
43.
Zurück zum Zitat Patrick K, Arny F, Juan L, Robert W, Evans WJ (2007) Effect of 10 days of bed rest on skeletal muscle in healthy older adults. Jama 297(16):1772–1774 Patrick K, Arny F, Juan L, Robert W, Evans WJ (2007) Effect of 10 days of bed rest on skeletal muscle in healthy older adults. Jama 297(16):1772–1774
44.
Zurück zum Zitat Evans WJ, Farrell PA (2011) The aging pancreas: effects of aging on insulin secretion and action Evans WJ, Farrell PA (2011) The aging pancreas: effects of aging on insulin secretion and action
45.
Zurück zum Zitat Matteo C, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BWHJ, Leon L, Palla SL, Ambrosius WT, Tracy RP, Marco P (2005) Sarcopenia, obesity, and inflammation—results from the trial of angiotensin converting enzyme inhibition and novel cardiovascular risk factors study. Am J Clin Nutr 82(2):428CrossRef Matteo C, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BWHJ, Leon L, Palla SL, Ambrosius WT, Tracy RP, Marco P (2005) Sarcopenia, obesity, and inflammation—results from the trial of angiotensin converting enzyme inhibition and novel cardiovascular risk factors study. Am J Clin Nutr 82(2):428CrossRef
46.
Zurück zum Zitat Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147(8):755–763CrossRefPubMed Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147(8):755–763CrossRefPubMed
47.
Zurück zum Zitat Evans WJ (2010) Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Am J Clin Nutr 91(4):1123S–1127SCrossRefPubMed Evans WJ (2010) Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Am J Clin Nutr 91(4):1123S–1127SCrossRefPubMed
48.
Zurück zum Zitat Chow WB, Rosenthal RA, Merkow RP, Ko CY, Esnaola NF (2012) Optimal preoperative assessment of the geriatric surgical patient: a best practices guideline from the American College of Surgeons National Surgical Quality Improvement Program and the American Geriatrics Society. J Am Coll Surg 215(4):453–466CrossRefPubMed Chow WB, Rosenthal RA, Merkow RP, Ko CY, Esnaola NF (2012) Optimal preoperative assessment of the geriatric surgical patient: a best practices guideline from the American College of Surgeons National Surgical Quality Improvement Program and the American Geriatrics Society. J Am Coll Surg 215(4):453–466CrossRefPubMed
Metadaten
Titel
Effect of sarcopenia on clinical outcomes following digestive carcinoma surgery: a meta-analysis
verfasst von
Hongxia Hua
Xinyi Xu
Yu Tang
Ziqi Ren
Qin Xu
Li Chen
Publikationsdatum
06.04.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 7/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04767-4

Weitere Artikel der Ausgabe 7/2019

Supportive Care in Cancer 7/2019 Zur Ausgabe

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.